COVID-19: New HCPCS Code for Convalescent Plasma in Outpatient Setting

On December 28, the FDA revised the emergency use authorization for COVID-19 convalescent plasma with high titers of anti-SARS-CoV-2 antibodies. It’s authorized for treatment of COVID-19 in patients with immunosuppressive disease or getting immunosuppressive treatment, in the outpatient or inpatient setting.

CMS created HCPCS code C9507 for COVID-19 convalescent plasma for use in the outpatient setting, effective on or after December 28:

• Long descriptor: Fresh frozen plasma, high titer COVID-19 convalescent, frozen within 8 hours of collection, each unit
• Short descriptor: COVID-19 convalescent plasma

If you need to submit claims, visit the Hospital Outpatient PPS webpage for billing and payment information.